Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2014

Open Access 01-12-2014 | Research article

Exercise training for asbestos-related and other dust-related respiratory diseases: a randomised controlled trial

Authors: Marita T Dale, Zoe J McKeough, Phillip A Munoz, Peter Corte, Peter T P Bye, Jennifer A Alison

Published in: BMC Pulmonary Medicine | Issue 1/2014

Login to get access

Abstract

Background

The study aimed to determine the short and long-term effects of exercise training on exercise capacity and health-related quality of life (HRQoL) compared to usual care in people with dust-related pleural and interstitial respiratory diseases. No previous studies have specifically evaluated exercise training in this patient population.

Methods

Participants with a diagnosis of a dust-related respiratory disease including asbestosis and asbestos related pleural disease were recruited and randomised to an eight-week exercise training group (EG) or a control group (CG) of usual care. Six-minute walk distance (6MWD), St George’s Respiratory Questionnaire (SGRQ) and Chronic Respiratory Disease Questionnaire (CRQ) were measured at baseline, eight weeks and 26 weeks by an assessor blinded to group allocation.

Results

Thirty-three of 35 male participants completed the study. Sixty-nine percent of participants had asbestos related pleural disease. At eight weeks, compared to the CG, the EG showed a significantly increased 6MWD (mean difference (95%CI)) 53 metres (32 to 74), improved SGRQ total score, -7 points (-13 to -1) and increased CRQ total score, 6.4 points (2.1 to 10.7). At 26 weeks significant between-group differences were maintained in 6MWD, 45 metres (17 to 73) and CRQ total score, 13.1 points (5.2 to 20.9).

Conclusion

Exercise training improved short and long-term exercise capacity and HRQoL in people with dust-related pleural and interstitial respiratory diseases.

Clinical trial registration number

ANZCTR1260800014​7381. Date trial registered: 27.03.2008.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kazan-Allen L: Asbestos and mesothelioma: worldwide trends. Lung Cancer. 2005, 49 (Suppl 1): S3-S8.CrossRefPubMed Kazan-Allen L: Asbestos and mesothelioma: worldwide trends. Lung Cancer. 2005, 49 (Suppl 1): S3-S8.CrossRefPubMed
2.
go back to reference Le GV, Takahashi K, Park E-K, Delgermaa V, Oak C, Qureshi AM, Aljunid SM: Asbestos use and asbestos-related diseases in Asia: past, present and future. Respirology. 2011, 16 (5): 767-775. 10.1111/j.1440-1843.2011.01975.x.CrossRefPubMed Le GV, Takahashi K, Park E-K, Delgermaa V, Oak C, Qureshi AM, Aljunid SM: Asbestos use and asbestos-related diseases in Asia: past, present and future. Respirology. 2011, 16 (5): 767-775. 10.1111/j.1440-1843.2011.01975.x.CrossRefPubMed
3.
go back to reference American Thoracic Society: Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004, 170 (6): 691-715.CrossRef American Thoracic Society: Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004, 170 (6): 691-715.CrossRef
4.
go back to reference Cugell DW, Kamp DW: Asbestos and the pleura: a review. Chest. 2004, 125 (3): 1103-1117. 10.1378/chest.125.3.1103.CrossRefPubMed Cugell DW, Kamp DW: Asbestos and the pleura: a review. Chest. 2004, 125 (3): 1103-1117. 10.1378/chest.125.3.1103.CrossRefPubMed
5.
go back to reference Lee YC, Singh B, Pang SC, de Klerk NH, Hillman DR, Musk AW: Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med. 2003, 60 (3): 201-206. 10.1136/oem.60.3.201.CrossRefPubMedPubMedCentral Lee YC, Singh B, Pang SC, de Klerk NH, Hillman DR, Musk AW: Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med. 2003, 60 (3): 201-206. 10.1136/oem.60.3.201.CrossRefPubMedPubMedCentral
6.
go back to reference Picado C, Laporta D, Grassino A, Cosio M, Thibodeau M, Becklake MR: Mechanisms affecting exercise performance in subjects with asbestos-related pleural fibrosis. Lung. 1987, 165 (1): 45-57. 10.1007/BF02714420.CrossRefPubMed Picado C, Laporta D, Grassino A, Cosio M, Thibodeau M, Becklake MR: Mechanisms affecting exercise performance in subjects with asbestos-related pleural fibrosis. Lung. 1987, 165 (1): 45-57. 10.1007/BF02714420.CrossRefPubMed
7.
go back to reference Chang JA, Curtis JR, Patrick DL, Raghu G: Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999, 116 (5): 1175-1182. 10.1378/chest.116.5.1175.CrossRefPubMed Chang JA, Curtis JR, Patrick DL, Raghu G: Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999, 116 (5): 1175-1182. 10.1378/chest.116.5.1175.CrossRefPubMed
8.
go back to reference Dale MT, McKeough ZJ, Munoz PA, Corte P, Bye PTP, Alison JA: Functional exercise capacity and health related quality of life in people with asbestos related pleural disease: an observational study. BMC Pulm Med. 2013, 13: 1-10.1186/1471-2466-13-1.CrossRefPubMedPubMedCentral Dale MT, McKeough ZJ, Munoz PA, Corte P, Bye PTP, Alison JA: Functional exercise capacity and health related quality of life in people with asbestos related pleural disease: an observational study. BMC Pulm Med. 2013, 13: 1-10.1186/1471-2466-13-1.CrossRefPubMedPubMedCentral
9.
go back to reference Wagner GR: Asbestosis and silicosis. Lancet. 1997, 349 (9061): 1311-1315. 10.1016/S0140-6736(96)07336-9.CrossRefPubMed Wagner GR: Asbestosis and silicosis. Lancet. 1997, 349 (9061): 1311-1315. 10.1016/S0140-6736(96)07336-9.CrossRefPubMed
10.
go back to reference Holland AE, Hill CJ, Conron M, Munro P, McDonald CF: Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008, 63 (6): 549-554. 10.1136/thx.2007.088070.CrossRefPubMed Holland AE, Hill CJ, Conron M, Munro P, McDonald CF: Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008, 63 (6): 549-554. 10.1136/thx.2007.088070.CrossRefPubMed
11.
go back to reference Nishiyama O, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, Watanabe F, Arizono S, Nishimura K, Taniguchi H: Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008, 13 (3): 394-399. 10.1111/j.1440-1843.2007.01205.x.CrossRefPubMed Nishiyama O, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, Watanabe F, Arizono S, Nishimura K, Taniguchi H: Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008, 13 (3): 394-399. 10.1111/j.1440-1843.2007.01205.x.CrossRefPubMed
12.
go back to reference Cockcroft AE, Saunders MJ, Berry G: Randomised controlled trial of rehabilitation in chronic respiratory disability. Thorax. 1981, 36 (3): 200-203. 10.1136/thx.36.3.200.CrossRefPubMedPubMedCentral Cockcroft AE, Saunders MJ, Berry G: Randomised controlled trial of rehabilitation in chronic respiratory disability. Thorax. 1981, 36 (3): 200-203. 10.1136/thx.36.3.200.CrossRefPubMedPubMedCentral
13.
go back to reference Dalichau S, Demedts A, im Sande A, Moller T: Short- and long-term effects of the outpatient medical rehabilitation for patients with asbestosis. Pneumologie. 2010, 64 (3): 163-170. 10.1055/s-0029-1215245.CrossRefPubMed Dalichau S, Demedts A, im Sande A, Moller T: Short- and long-term effects of the outpatient medical rehabilitation for patients with asbestosis. Pneumologie. 2010, 64 (3): 163-170. 10.1055/s-0029-1215245.CrossRefPubMed
14.
go back to reference Garcia-Aymerich J, Serra I, Gomez FP, Farrero E, Balcells E, Rodriguez DA, de Batlle J, Gimeno E, Donaire-Gonzalez D, Orozco-Levi M, Sauleda J, Gea J, Rodriguez-Roisin R, Roca J, Agusti AG, Anto JM: Physical activity and clinical and functional status in COPD. Chest. 2009, 136 (1): 62-70. 10.1378/chest.08-2532.CrossRefPubMed Garcia-Aymerich J, Serra I, Gomez FP, Farrero E, Balcells E, Rodriguez DA, de Batlle J, Gimeno E, Donaire-Gonzalez D, Orozco-Levi M, Sauleda J, Gea J, Rodriguez-Roisin R, Roca J, Agusti AG, Anto JM: Physical activity and clinical and functional status in COPD. Chest. 2009, 136 (1): 62-70. 10.1378/chest.08-2532.CrossRefPubMed
15.
go back to reference Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM: Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006, 61 (9): 772-778. 10.1136/thx.2006.060145.CrossRefPubMedPubMedCentral Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM: Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006, 61 (9): 772-778. 10.1136/thx.2006.060145.CrossRefPubMedPubMedCentral
16.
go back to reference Park EK, Hannaford-Turner KM, Hyland RA, Johnson AR, Yates DH: Asbestos-related occupational lung diseases in NSW, Australia and potential exposure of the general population. Ind Health. 2008, 46 (6): 535-540. 10.2486/indhealth.46.535.CrossRefPubMed Park EK, Hannaford-Turner KM, Hyland RA, Johnson AR, Yates DH: Asbestos-related occupational lung diseases in NSW, Australia and potential exposure of the general population. Ind Health. 2008, 46 (6): 535-540. 10.2486/indhealth.46.535.CrossRefPubMed
17.
go back to reference Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O’Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006, 173 (12): 1390-1413. 10.1164/rccm.200508-1211ST.CrossRefPubMed Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O’Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006, 173 (12): 1390-1413. 10.1164/rccm.200508-1211ST.CrossRefPubMed
18.
19.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 16: 5-40.CrossRefPubMed Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 16: 5-40.CrossRefPubMed
20.
go back to reference Crapo RO, Morris AH: Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis. 1981, 123 (2): 185-189.PubMed Crapo RO, Morris AH: Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis. 1981, 123 (2): 185-189.PubMed
21.
go back to reference Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999, 159 (1): 179-187. 10.1164/ajrccm.159.1.9712108.CrossRefPubMed Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999, 159 (1): 179-187. 10.1164/ajrccm.159.1.9712108.CrossRefPubMed
22.
go back to reference ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002, 166 (1): 111-117.CrossRef ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002, 166 (1): 111-117.CrossRef
23.
go back to reference ERS Task Force on Standardization of Clinical Exercise Testing: Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. Eur Respir J. 1997, 10 (11): 2662-2689.CrossRef ERS Task Force on Standardization of Clinical Exercise Testing: Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. Eur Respir J. 1997, 10 (11): 2662-2689.CrossRef
24.
go back to reference Oga T, Nishimura K, Tsukino M, Sato S: Exercise responses during endurance testing at different intensities in patients with COPD. Respir Med. 2004, 98 (6): 515-521. 10.1016/j.rmed.2003.12.009.CrossRefPubMed Oga T, Nishimura K, Tsukino M, Sato S: Exercise responses during endurance testing at different intensities in patients with COPD. Respir Med. 2004, 98 (6): 515-521. 10.1016/j.rmed.2003.12.009.CrossRefPubMed
25.
go back to reference Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N: Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis. 1985, 131 (5): 700-708.PubMed Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N: Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis. 1985, 131 (5): 700-708.PubMed
26.
go back to reference Jaeschke R, Singer J, Guyatt GH: Measurement of health status: Ascertaining the minimal clinically important difference. Control Clin Trials. 1989, 10 (4): 407-415. 10.1016/0197-2456(89)90005-6.CrossRefPubMed Jaeschke R, Singer J, Guyatt GH: Measurement of health status: Ascertaining the minimal clinically important difference. Control Clin Trials. 1989, 10 (4): 407-415. 10.1016/0197-2456(89)90005-6.CrossRefPubMed
27.
go back to reference Watz H, Waschki B, Meyer T, Magnussen H: Physical activity in patients with COPD. Eur Respir J. 2009, 33 (2): 262-272.CrossRefPubMed Watz H, Waschki B, Meyer T, Magnussen H: Physical activity in patients with COPD. Eur Respir J. 2009, 33 (2): 262-272.CrossRefPubMed
28.
go back to reference Lacasse Y, Goldstein R, Lasserson TJ, Martin S: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006, 4: CD003793-PubMed Lacasse Y, Goldstein R, Lasserson TJ, Martin S: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006, 4: CD003793-PubMed
29.
go back to reference Laviolette L, Bourbeau J, Bernard S, Lacasse Y, Pepin V, Breton MJ, Baltzan M, Rouleau M, Maltais F: Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax. 2008, 63 (2): 115-121.CrossRefPubMed Laviolette L, Bourbeau J, Bernard S, Lacasse Y, Pepin V, Breton MJ, Baltzan M, Rouleau M, Maltais F: Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax. 2008, 63 (2): 115-121.CrossRefPubMed
30.
go back to reference Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, Schunemann HJ: Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J. 2008, 32 (3): 637-643. 10.1183/09031936.00140507.CrossRefPubMed Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, Schunemann HJ: Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J. 2008, 32 (3): 637-643. 10.1183/09031936.00140507.CrossRefPubMed
31.
go back to reference Holland AE, Hill CJ, Conron M, Munro P, McDonald CF: Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. Respir Med. 2009, 103 (10): 1430-1435. 10.1016/j.rmed.2009.04.024.CrossRefPubMed Holland AE, Hill CJ, Conron M, Munro P, McDonald CF: Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. Respir Med. 2009, 103 (10): 1430-1435. 10.1016/j.rmed.2009.04.024.CrossRefPubMed
32.
go back to reference Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, Wise RA, Sciurba F, National Emphysema Treatment Trial Research Group: The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011, 37 (4): 784-790. 10.1183/09031936.00063810.CrossRefPubMed Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, Wise RA, Sciurba F, National Emphysema Treatment Trial Research Group: The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011, 37 (4): 784-790. 10.1183/09031936.00063810.CrossRefPubMed
33.
go back to reference Jones PW: Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002, 19 (3): 398-404. 10.1183/09031936.02.00063702.CrossRefPubMed Jones PW: Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002, 19 (3): 398-404. 10.1183/09031936.02.00063702.CrossRefPubMed
34.
go back to reference Blackstock FC, Webster KE, McDonald CF, Hill CJ: Comparable improvements achieved in chronic obstructive pulmonary disease through pulmonary rehabilitation with and without a structured educational intervention: a randomized controlled trial. Respirology. 2014, 19: 193-202. 10.1111/resp.12203.CrossRefPubMed Blackstock FC, Webster KE, McDonald CF, Hill CJ: Comparable improvements achieved in chronic obstructive pulmonary disease through pulmonary rehabilitation with and without a structured educational intervention: a randomized controlled trial. Respirology. 2014, 19: 193-202. 10.1111/resp.12203.CrossRefPubMed
35.
go back to reference Ng LW, Mackney J, Jenkins S, Hill K: Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis. 2012, 9 (1): 17-26. 10.1177/1479972311430335.CrossRef Ng LW, Mackney J, Jenkins S, Hill K: Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis. 2012, 9 (1): 17-26. 10.1177/1479972311430335.CrossRef
Metadata
Title
Exercise training for asbestos-related and other dust-related respiratory diseases: a randomised controlled trial
Authors
Marita T Dale
Zoe J McKeough
Phillip A Munoz
Peter Corte
Peter T P Bye
Jennifer A Alison
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2014
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-14-180

Other articles of this Issue 1/2014

BMC Pulmonary Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.